GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24604
Abstract: This study strived to explore the role and mechanism of glucagon‐like peptide‐1 receptor (GLP1R) in endometrial carcinoma (EC). read more here.
Keywords: inhibits progression; endometrial carcinoma; progression endometrial; glp1r inhibits ... See more keywords